πŸ‡ΊπŸ‡Έ FDA
Patent

US 10751416

IL-26 inhibitors

granted A61KA61K2039/505A61K2300/00

Quick answer

US patent 10751416 (IL-26 inhibitors) held by The Board of Regents of the University of Texas System expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505, A61K2300/00, A61K31/194, A61K31/505